Koninklijke Philips (Philips)

<
>
How to read and use this data card.
LOADING...
1717450
c0cf078a46bd46ff8eafb782b9ee2f83

Lobbying costs:

WARNING: As this organisation lists one or more EP accredited lobbyists, it is highly improbable that its lobbying costs are lower than €10,000.

WARNING: The lobbying costs declared by this organisation are extraordinarily high and may therefore have been over-declared.

800,000€ - 899,999€

Financial year: 01/01/2017 - 01/12/2017

Lobbyists declared: 2.5 FTE (4)

WARNING: The number of full time equivalent lobbyists declared by this organisation are extraordinarily high and may therefore have been over-declared.

1
1

Lobbyists with EP accreditation: 2

1
1

Meetings with European Commission: 21

Lobbying costs over the years:

1
5
10
100
1000

Koninklijke Philips (Philips)

Registration on EU Transparency Register

035366013790-68 (First registered: 18 Jun 2014)

Goals / Remit

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2017 sales of EUR 17.8 billion and employs approximately 74,000 employees with sales and services in more than 100 countries.

Issues

Health, digital economy & society, international cooperation and development, trade, regional policy, research, science and innovation

Address

Head office:
Amstelplein, 2
Amsterdam 1096 BC,
Netherlands

Tel: 31 205977777

Belgium office:
Square de Meeus 23
Brussels 1000,
Belgium

Tel: 32 2 525 6008